Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 8, 2008, Pages 2981-2986

  McMurtrey, Curtis P ^a   Lelic, Alina ^b   Piazza, Paolo ^c   Chakrabarti, Ayan K ^c   Yablonsky, Eric J ^c   Wahl, Angela ^a   Bardet, Wilfried ^a   Eckerd, Annette ^a   Cook, Robert L ^d   Hess, Rachael ^e   Buchli, Rico ^f   Loeb, Mark ^b   Rinaldo, Charles R ^c   Bramson, Jonathan ^b   Hildebrand, William H ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF FLORIDA HEALTH   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f Pure Protein LLC   (United States)

Author keywords

Epitope hierarchy; Human leukocyte antigen; Immunodominance; Major histocompatibility complex; Mass spectrometry

Indexed keywords

EPITOPE; GLYCOPROTEIN E1; HLA ANTIGEN CLASS 1; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5; PROTEOME; HLA ANTIGEN; PRIMER DNA;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN PURIFICATION; T LYMPHOCYTE; VIRUS INFECTION; VIRUS ISOLATION; VIRUS STRAIN; WEST NILE FLAVIVIRUS; ANIMAL; CERCOPITHECUS; COMPARATIVE STUDY; DNA SEQUENCE; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SEQUENCE HOMOLOGY; VERO CELL;

WEST NILE VIRUS;

ANIMALS; BASE SEQUENCE; CERCOPITHECUS AETHIOPS; DNA PRIMERS; EPITOPES, T-LYMPHOCYTE; HLA ANTIGENS; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; VERO CELLS; WEST NILE FEVER; WEST NILE VIRUS;

EID: 42949089087     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0711874105     Document Type: Article

References (30)

1. Hayes EB, et al. (2005) Epidemiology and transmission dynamics of West Nile virus disease. Emerging Infect Dis 11:1167-1173.
2. Bunning ML, et al. (2001) Experimental infection of horses with West Nile virus and their potential to infect mosquitoes and serve as amplifying hosts. Ann NY Acad Sci 951:338-339.
3. Sejvar JJ, et al. (2003) Neurologic manifestations and outcome of West Nile virus infection. J Am Med Assoc 290:511-515.
4. Brinton MA (2002) The molecular biology of West Nile virus: A new invader of the Western hemisphere. Annu Rev Microbiol 56:371-402.
5. Jerzak G, Bernard KA, Kramer LD, Ebel GD (2005) Genetic variation in West Nile virus from naturally infected mosquitoes and birds suggests quasispecies structure and strong purifying selection. J Gen Virol 86:2175-2183.
6. Samuel MA, Diamond MS (2006) Pathogenesis of West Nile virus infection: A balance between virulence, innate and adaptive immunity, and viral evasion. J Virol 80:9349-9360.
7. Ben-Nathan D, et al. (2003) Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice. J Infect Dis 188:5-12.
8. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M (2003) B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77:2578-2586.
9. Oliphant T, et al. (2005) Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med 11:522-530.
10. Kesson AM, Blanden RV, Mullbacher A (1987) The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile. J Gen Virol 68:2001-2006.
11. Wang Y, Lobigs M, Lee E, Koskinen A, Mullbacher A (2006) CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of γ-interferon. J Gen Virol 87:3599-3609.
12. + T cells in control of West Nile virus infection. J Virol 78:8312-8321.
13. + T cells require perforin to clear West Nile virus from infected neurons. J Virol 80:119-129.
14. Wahl A, Weidanz J, Hildebrand W (2006) Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells. Expert Rev Proteomics 3:641-652.
15. Buchli R, et al. (2005) Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201: A new tool for epitope discovery. Biochemistry 44:12491-12507.
16. Brien JD, Uhrlaub JL, Nikolich-Zugich J (2007) Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur J Immunol 37:1855-1863.
17. Purtha WE, et al. (2007) Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol 37:1845-1854.
18. Hickman-Miller HD, et al. (2005) Rhesus macaque MHC class I molecules present HLA-B-like peptides. J Immunol 175:367-375.
19. Papin JF, Vahrson W, Dittmer DP (2004) SYBR green-based real-time quantitative PCR assay for detection of West Nile virus circumvents false-negative results due to strain variability. J Clin Microbiol 42:1511-1518.
20. Lanciotti RS, et al. (2000) Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 38:4066-4071.
21. Borzi RM, et al. (1996) A fluorescent in situ hybridization method in flow cytometry to detect HIV-1-specific RNA. J Immunol Methods 193:167-176.
22. Hickman HD, et al. (2004) Toward a definition of self: Proteomic evaluation of the class I peptide repertoire. J Immunol 172:2944-2952.
23. Prilliman K, et al. (1997) Large-scale production of class I bound peptides: Assigning a signature to HLA-B*1501. Immunogenetics 45:379-385.
24. Prilliman K, et al. (1999) HLA-B15 peptide ligands are preferentially anchored at their C termini. J Immunol 162:7277-7284.
25. Hickman HD, et al. (2000) C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I-positive cells. Hum Immunol 61:1339-1346.
26. Disis ML, et al. (2006) Maximizing the retention of antigen-specific lymphocyte function after cryopreservation. J Immunol Methods 308:13-18.
27. Peters B, et al. (2005) The immune epitope database and analysis resource: From vision to blueprint. PLoS Biol 3:e91.
28. Bihl FK, et al. (2005) Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti-CD3 mAb T cell expansion, and "RecycleSpot." J Transl Med 3:20-39.
29. Huang XL, et al. (2005) Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons. J Virol 79:3052-3062.
30. Currier JR, et al. (2002) A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods 260:157-172.